These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6196421)

  • 1. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
    Naughton GK; Eisinger M; Bystryn JC
    J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
    Park YK; Kim NS; Hann SK; Im S
    J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
    Cui J; Bystryn JC
    Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
    Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic antibodies to melanocytes in vitiligo.
    Cui J; Arita Y; Bystryn JC
    J Invest Dermatol; 1993 Jun; 100(6):812-5. PubMed ID: 8496621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis.
    Howanitz N; Nordlund JL; Lerner AB; Bystryn JC
    Arch Dermatol; 1981 Nov; 117(11):705-8. PubMed ID: 7316530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
    Norris DA; Kissinger RM; Naughton GM; Bystryn JC
    J Invest Dermatol; 1988 Jun; 90(6):783-9. PubMed ID: 3373009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
    Chen JP; Li HP; Jin SH; Zhang JT; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo.
    Austin LM; Boissy RE; Jacobson BS; Smyth JR
    Clin Immunol Immunopathol; 1992 Aug; 64(2):112-20. PubMed ID: 1643744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
    Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
    N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
    Yu HS; Kao CH; Yu CL
    J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo and antibodies to melanocytes.
    Bystryn JC; Pfeffer S
    Prog Clin Biol Res; 1988; 256():195-206. PubMed ID: 3285350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vitiligo antigen on a revertant line of hamster melanoma cells.
    Naughton GK; Lipkin G; Bystryn JC
    J Invest Dermatol; 1984 Nov; 83(5):317-9. PubMed ID: 6386993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC; Liu CG; Wang DX; Zhan Z
    Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
    Hann SK; Kim JB
    Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo autoantibodies are effective against melanoma.
    Fishman P; Azizi E; Shoenfeld Y; Sredni B; Yecheskel G; Ferrone S; Zigelman R; Chaitchik S; Floro S; Djaldetti M
    Cancer; 1993 Oct; 72(8):2365-9. PubMed ID: 8402450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of antibodies to melanoma cells in vitiligo by 125I-labeled SpA antibody binding assay].
    Mori N; Shimada K; Satoh N; Nagao S; Iijima S; Kanzaki T
    Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):835-8. PubMed ID: 3784053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.